REGULATORY

• Japan Mulls Target on “Social Security Burden Rate” after CEFP Call
  May 25, 2026

• Update: Tavneos Slapped with Blue Letter Action in Japan over Liver Injury Risk
  May 22, 2026

• Blister Pack Supplies Seen Returning to Normal: Health Minister
  May 22, 2026

• LDP “Eto” Study Group Submits Honebuto Proposal to Health Minister
  May 22, 2026

• Oncolys’ Telomelysin Wins Backing from Japan Panel
  May 22, 2026

• MHLW Moves Toward Immunization Act Revision for RSV Antibody Drugs
  May 21, 2026

• Japan Approves Nonprescription Cialis, Rozerem
  May 21, 2026

• MHLW Panel Clarifies Roles in Vaccine Policy Review Process
  May 21, 2026

• Japan to Start CEA Technical Discussions as Early as May 25
  May 20, 2026

• LDP Study Group’s Honebuto Proposal Urges “Freeze” on On-Patent Drug Price Cuts
  May 20, 2026

• PMDA Flags Iron Products, ST Combination Drug in Risk Review
  May 20, 2026

• MHLW Orders Detailed Report on Tavneos Efficacy Concerns
  May 20, 2026

• Japan Approves Jascayd, mNEXSPIKE, Zepbound OSA Use, Others
  May 19, 2026

• Japan to List 1st Biosimilars for Xolair, Ranmark, Simponi on May 20
  May 19, 2026

• Japan Provides Stockpiled Avigan to UK for Hantavirus Prevention
  May 19, 2026

• 800 More Entities Seek War-Tied Supply Consultation as Future Anxiety Spreads
  May 19, 2026

• Japan to Swiftly Consider Safety Measures over Tavneos: Minister
  May 19, 2026

• Japan Gives Orphan Tag to Revolution’s Pancreatic Cancer Drug, Others
  May 19, 2026

• Wegovy’s MASH Label Expansion and More Up for Japan Panel Review on May 29
  May 18, 2026

• Japan Eyes June Submission of Immunization Act Bill to Cover Antibody Drugs
  May 18, 2026

ページ

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »